The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of ...

By combining our strengths, we aim to change how science advances, unlocking new ways to accelerate scientific progress.” “We ...

The thalassemia market is primarily driven by regular blood transfusions and iron chelation therapies, which help manage anemia and prevent iron overload. Curative treatments, such as stem cell ...

Pfizer acquires Metsera to enter the booming obesity drug market with next-gen GLP-1 therapies. Find out why PFE stock is a ...

Gloperba® is the subject of an exclusive, transferable license to use the registered trademark by Scilex Holding Company. ELYXYB® is a registered trademark owned by Scilex Holding Company. Scilex Bio™ ...

A novel substance disrupts stress management in cancer cells and offers new therapeutic approaches to treating tumours.

At this year’s LSX World Congress in Boston, an entire track was devoted to Obesity Science and Innovation, with pharma ...

Innovent Biologics' newly launched weight-loss drug is making inroads in its home market of China, ramping up competition ...

Artificial intelligence has taken many forms over the years and is still evolving. Will machines soon surpass human knowledge ...

Siemens and Merck hope AI and other technologies can close production gaps and tackle rising costs in the drug market.

While awareness about heat death rates grows, attention to underlying causes of heat-related hospital visits lags, experts ...